At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Vaxcyte's VAX-24 Phase 2 trial showed a safety profile similar to PCV20, with strong immune responses and no serious vaccine-related adverse events.

WASHINGTON (AP) — The top vaccine official with the Food and Drug Administration has resigned and criticized the nation’s top health official for allowing “misinformation and lies” to ...

Pfizer PFE is a key player in the PCV vaccine space. PFE markets Prevnar 20, which is approved for the prevention of IPD caused by 20 serotypes in individuals aged six weeks and older. PFE also ...

The decision was influenced by the positive recommendation from the EMA’s Committee for Medicinal Products for Human Use.

Soon after President Trump won the presidential election in November, British drugmaker GSK brought an unusual claim to federal prosecutors in Manhattan, according to people familiar with the ...

Participants were randomized to receive a single dose of either one of three lots of CAPVAXIVE or PPSV23 (pneumococcal 23-valent polysaccharide ... received a pneumococcal vaccine at least one ...

Vaccines may or may not be required by schools or employers depending on the specific vaccine and what the state and local laws are in your area. In some places, proof of vaccination is required for ...

Currently available PCVs for the recommended age group include Pfizer’s Prevnar 20 and Merck’s Capvaxive. To get the word out about the expanded guidelines and the risk of pneumococcal disease ...